Transvaginal placement of surgical mesh for pelvic organ prolapse: more FDA concerns--positive reactions are possible.

Transvaginal placement of surgical mesh for pelvic organ prolapse: more FDA concerns--positive reactions are possible. Int Urogynecol J. 2012 Jan; 23(1):11-3.

View in: PubMed

subject areas

Female
Humans
Patient Safety
Pelvic Organ Prolapse
Prosthesis Failure
Prosthesis Implantation
Surgical Mesh
United States
United States Food and Drug Administration

authors with profiles

Peter Sand